NASDAQ:BEAT - Nasdaq - US42238H1086 - Common Stock - Currency: USD
NASDAQ:BEAT (4/25/2025, 8:00:01 PM)
1.99
+0.07 (+3.65%)
The current stock price of BEAT is 1.99 USD. In the past month the price decreased by -1%. In the past year, price decreased by -0.5%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 26.96 | 223.47B | ||
ISRG | INTUITIVE SURGICAL INC | 67.35 | 184.36B | ||
BSX | BOSTON SCIENTIFIC CORP | 37.74 | 150.72B | ||
SYK | STRYKER CORP | 29.95 | 139.34B | ||
MDT | MEDTRONIC PLC | 15.76 | 107.94B | ||
BDX | BECTON DICKINSON AND CO | 14.74 | 58.89B | ||
EW | EDWARDS LIFESCIENCES CORP | 29.25 | 44.70B | ||
IDXX | IDEXX LABORATORIES INC | 38.88 | 35.45B | ||
RMD | RESMED INC | 25.98 | 34.64B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 15.24 | 31.33B | ||
DXCM | DEXCOM INC | 43.43 | 28.10B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 15.84 | 23.53B |
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. The company is headquartered in Santa Clara, California and currently employs 21 full-time employees. The company went IPO on 2021-10-14. The firm focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The company is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. The company is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. The company is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.
HEARTBEAM INC
2118 Walsh Ave., Suite 210
Santa Clara CALIFORNIA 19355 US
CEO: Joseph H. Capper
Employees: 15
Company Website: https://www.heartbeam.com/
Investor Relations: https://ir.heartbeam.com/
Phone: 14088994443
The current stock price of BEAT is 1.99 USD. The price increased by 3.65% in the last trading session.
The exchange symbol of HEARTBEAM INC is BEAT and it is listed on the Nasdaq exchange.
BEAT stock is listed on the Nasdaq exchange.
8 analysts have analysed BEAT and the average price target is 5.1 USD. This implies a price increase of 156.28% is expected in the next year compared to the current price of 1.99. Check the HEARTBEAM INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
HEARTBEAM INC (BEAT) has a market capitalization of 67.12M USD. This makes BEAT a Micro Cap stock.
HEARTBEAM INC (BEAT) currently has 15 employees.
HEARTBEAM INC (BEAT) has a support level at 1.98 and a resistance level at 2.17. Check the full technical report for a detailed analysis of BEAT support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BEAT does not pay a dividend.
HEARTBEAM INC (BEAT) will report earnings on 2025-05-08, after the market close.
HEARTBEAM INC (BEAT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.73).
The outstanding short interest for HEARTBEAM INC (BEAT) is 0.58% of its float. Check the ownership tab for more information on the BEAT short interest.
ChartMill assigns a technical rating of 2 / 10 to BEAT. When comparing the yearly performance of all stocks, BEAT turns out to be only a medium performer in the overall market: it outperformed 47.28% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to BEAT. BEAT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months BEAT reported a non-GAAP Earnings per Share(EPS) of -0.73. The EPS increased by 22.34% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -593.65% | ||
ROE | -1175.82% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 80% to BEAT. The Buy consensus is the average rating of analysts ratings from 8 analysts.